Compass Pathways established its operational footprint as of July 2025, including headquarters in London, offices in New York, and Breakthrough Therapy designation from the FDA.
3 reports, 1 independent
Updated Jul 29
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Compass Pathways established its operational footprint as of July 2025, including headquarters in London, offices in New York, and Breakthrough Therapy designation from the FDA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- RBC Capital Markets provides analyst commentary regarding the FDA's regulation of psychedelic drug development at Compass.Sub-event
Compass Pathways is headquartered in London, with offices in New York, and holds Breakthrough Therapy designation from the FDA.1 source
Keep exploring
The entities involved
-
Compass Pathways
mental health care company
-
London
capital and largest city of England and the United Kingdom
- FDA
-
New York City
most populous city in the United States
Coverage
Newest first; wire copies grouped- Business WireCompass Pathways to Announce Second Quarter Financial Results on July 31, 2025 Compass management will host a conference call at 8:00 am ET (1:00 pm UK) LONDON & NEW YORK, July 22, 2025--(BUSINESS WI
- Unknown outlet